Literature DB >> 31255510

How to reposition the benefice-risk balance to safely transfuse patients in non-vital situations?

O Garraud1.   

Abstract

It appears that the vast majority of review articles on transfusion deal with complications rather than benefits of this supportive therapy. However, deduced from reports compiled by hemovigilance systems, the majority of transfusion procedures do not lead to complications; rather, the majority of prescriptions of blood components generate measurable benefits in the transfused patient. This short review attempts to analyze the causes for such a discrepancy between benefits and complications in the literature and in the everyday life in wards and introduces the role of Patient Blood Management in this understanding.
Copyright © 2019 Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Benefits; Bénéfices; Complications; Management du sang; Patient blood management; Quality; Qualité; Transfusion

Mesh:

Year:  2019        PMID: 31255510     DOI: 10.1016/j.tracli.2019.06.006

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  2 in total

Review 1.  How do I see the production of engineered blood cells available for transfusion?

Authors:  Olivier Garraud
Journal:  Transfus Apher Sci       Date:  2020-06-29       Impact factor: 1.764

2.  Transfusion medicine: Overtime paradigm changes and emerging paradoxes.

Authors:  O Garraud; T Vuk; M Lozano; J-D Tissot
Journal:  Transfus Clin Biol       Date:  2020-10-06       Impact factor: 1.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.